Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low Sodium Oxybate for Nocturnal Cluster Headache
NCT06950281Phase 2Not yet recruiting
- Sponsor
- Leiden University Medical Center
- Start
- Dec 2026
- Primary completion
- Dec 2028
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of sodium oxybate + calcium oxybate + potassium oxybate + magnesium oxybate in Cluster Headache (CH), sponsored by Leiden University Medical Center. Planned start Dec 2026; status: not yet recruiting.
02
Drugs
sodium oxybate + calcium oxybate + potassium oxybate + magnesium oxybate
03
Conditions
Cluster Headache (CH)
Beyond the preview
Go deeper on NCT06950281.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06950281.